Patents by Inventor Peter Dove

Peter Dove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8106043
    Abstract: The present invention features benzothiazines that inhibit nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms, and that have the formula: The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions.
    Type: Grant
    Filed: July 6, 2009
    Date of Patent: January 31, 2012
    Assignee: NeurAxon, Inc.
    Inventors: Jailall Ramnauth, Subhash C. Annedi, Sarah Silverman, Peter Dove, Shawn Maddaford, Suman Rakhit
  • Patent number: 7772235
    Abstract: The present invention is directed to compounds of formula I: Wherein R1 to R5, X and Z are further defined in the description. The invention also relates to processes for the preparation of the compounds and to intermediates used in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.
    Type: Grant
    Filed: September 25, 2007
    Date of Patent: August 10, 2010
    Assignee: Astrazeneca AB
    Inventors: Methvin Isaac, Abdelmalik Slassi, Louise Edwards, Peter Dove, Tao Xin, Tomislav Stefanac
  • Publication number: 20100009975
    Abstract: The present invention features benzoxazines, benzothiazines, and related compounds that inhibit nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions.
    Type: Application
    Filed: July 6, 2009
    Publication date: January 14, 2010
    Inventors: Jailall Ramnauth, Subhash C. Annedi, Sarah Silverman, Peter Dove, Shawn Maddaford, Suman Rakhit
  • Publication number: 20090111857
    Abstract: The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
    Type: Application
    Filed: October 24, 2008
    Publication date: April 30, 2009
    Applicant: AstraZeneca AB
    Inventors: Peter DOVE, Kenneth Granberg, Methvin Isaac, Mats Nagard, Abdelmalik Slassi
  • Publication number: 20080312240
    Abstract: The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar1, A, Hy, R1, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR5-mediated disorders.
    Type: Application
    Filed: August 4, 2006
    Publication date: December 18, 2008
    Applicant: AstraZeneca AB
    Inventors: Louise Edwards, Methvin Isaac, Abdelmalik Slassi, Guang-Ri Sun, Tao Xin, Alexander Minidis, Peter Dove
  • Publication number: 20080234237
    Abstract: The present invention features quinolones, tetrahydroquinolines, and related compounds that inhibit nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions.
    Type: Application
    Filed: March 24, 2008
    Publication date: September 25, 2008
    Inventors: Shawn MADDAFORD, Jailall RAMNAUTH, Suman RAKHIT, Joanne PATMAN, Subhash C. ANNEDI, John ANDREWS, Peter DOVE, Sarah SILVERMAN, Paul Renton
  • Publication number: 20080194571
    Abstract: The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar1, A, B, R1, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR 5 mediated disorders.
    Type: Application
    Filed: August 4, 2006
    Publication date: August 14, 2008
    Applicant: AstraZeneca AB
    Inventors: Louise Edwards, Mithvin Isaac, Abdelmalik Slassi, Guang-Ri Sun, Peter Dove, Erwan Arzel
  • Publication number: 20080125436
    Abstract: The present invention is directed to compounds of formula I: Wherein R1 to R5, X and Z are further defined in the description. The invention also relates to processes for the preparation of the compounds and to intermediates used in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.
    Type: Application
    Filed: September 25, 2007
    Publication date: May 29, 2008
    Applicant: AstraZeneca AB
    Inventors: Methvin Isaac, Abdelmalik Slassi, Louise Edwards, Peter Dove, Tao Xin, Tomislav Stefanac
  • Publication number: 20070259895
    Abstract: The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
    Type: Application
    Filed: April 25, 2007
    Publication date: November 8, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS, INC.
    Inventors: Methvin Isaac, Abdelmalik Slassi, Louise Edwards, Tao Xin, Tomislav Stefanac, Peter Dove, Mats Nagard
  • Publication number: 20070259860
    Abstract: The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
    Type: Application
    Filed: April 25, 2007
    Publication date: November 8, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS, INC.
    Inventors: Andreas Wallberg, Karolina Nilsson, Kenneth Granberg, Saswati Ghosal, Abdelmalik Slassi, Louise Edwards, Methvin Isaac, Tao Xin, Tomislav Stefanac, Peter Dove
  • Publication number: 20070049578
    Abstract: The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where R1, R2, R3, A, X, and n are defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR 5 mediated disorders.
    Type: Application
    Filed: August 14, 2006
    Publication date: March 1, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS
    Inventors: Louise Edwards, Methvin Isaac, Abdelmalik Slassi, Tao Xin, Peter Dove
  • Publication number: 20070037817
    Abstract: The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar1, A, B, R1, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR 5 mediated disorders.
    Type: Application
    Filed: August 4, 2006
    Publication date: February 15, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS
    Inventors: Louise Edwards, Methvin Isaac, Abdelmalik Slassi, Guang-Ri Sun, Peter Dove, Erwan Arzel
  • Publication number: 20070037816
    Abstract: The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar1, A, Hy, R1, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR5-mediated disorders.
    Type: Application
    Filed: August 4, 2006
    Publication date: February 15, 2007
    Applicants: AstraZeneca AB, NPS Pharmaceuticals
    Inventors: Louise Edwards, Methvin Isaac, Abdelmalik Slassi, Guang-Ri Sun, Tao Xin, Alexander Minidis, Peter Dove
  • Patent number: 7026496
    Abstract: The present invention relates to a complex having the formula (I) wherein M is selected from Sn(II), Sn(IV), Al(III) and Mg(II); each of R1 and R2 is independently hydrocarbyl; R3 is H or hydrocarbyl; and X is a linker group. A further aspect of the invention relates to the use of said complex as a polymerisation initiator, particularly in the polymerisation of lactides.
    Type: Grant
    Filed: November 8, 2001
    Date of Patent: April 11, 2006
    Assignee: Imperial College Innovations Limited
    Inventors: Vernon Charles Gibson, Edward Leslie Marshall, Andrew Peter Dove
  • Publication number: 20060060126
    Abstract: In a method of and apparatus for offshore mooring, a clamping apparatus includes a clamping mechanism and a pulley. A mooring line connected to an anchor or a pendant line connected to a vessel to be moored extends through the clamping mechanism and around the pulley of the clamping apparatus. The distal end of the line extending through the clamping apparatus is connected to an anchor handling vessel. The anchor handling vessel is employed to apply a predetermined tension to the pendant line and the preset mooring line. A remote operated vehicle is then employed to actuate the clamping apparatus and to disengage the anchor handling vessel.
    Type: Application
    Filed: November 14, 2005
    Publication date: March 23, 2006
    Applicant: TECHNIP FRANCE
    Inventors: Peter Dove, Johannes Treu
  • Patent number: 6122847
    Abstract: In a method of and apparatus for anchor installation, a plate anchor is mounted at the bottom of a suction follower comprising a hollow cylinder having an open lower insertion end and a closable upper suspension end. The suction follower and the anchor secured thereto are engaged with the sea floor, whereupon water is pumped out of the suction follower causing the suction follower and the anchor to penetrate into the sea floor to a predetermined depth. The anchor is then disengaged from the suction follower, whereupon water is pumped into the suction follower to disengage the suction follower from the sea floor for recovery to the surface, leaving the anchor embedded in the sea floor. The plate anchor may comprise first and second plate members, the second plate member pivoting relative to the first plate member to prevent upward movement of the anchor.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: September 26, 2000
    Assignee: Aker Marine Contractors, Inc.
    Inventors: Johannes J. Treu, Gordon R. Wilde, Peter Dove